Cancer Research Cancer Research Funding Available  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

Cancer Research 68, 9087, November 1, 2008. doi: 10.1158/0008-5472.CAN-08-0400
© 2008 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Studebaker, A. W.
Right arrow Articles by Hall, B. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Studebaker, A. W.
Right arrow Articles by Hall, B. M.

Tumor Microenvironment

Fibroblasts Isolated from Common Sites of Breast Cancer Metastasis Enhance Cancer Cell Growth Rates and Invasiveness in an Interleukin-6–Dependent Manner

Adam W. Studebaker1, Gianluca Storci5,6, Jillian L. Werbeck2, Pasquale Sansone5,7, A. Kate Sasser1,3, Simona Tavolari8, Tim Huang4, Michael W.Y. Chan9, Frank C. Marini10, Thomas J. Rosol2, Massimiliano Bonafé5,6 and Brett M. Hall1,3

1 Center for Childhood Cancer, Children's Research Institute; 2 Department of Veterinary Biosciences, College of Veterinary Medicine, 3 Integrated Biomedical Science Graduate Program, Department of Pediatrics, School of Medicine and Public Health, and 4 Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, The Ohio State University, Columbus, Ohio; 5 Center for Applied Biomedical Research, St. Orsola-Malpighi University Hospital, 6 Department of Experimental Pathology, 7 Department of Pharmacology and Toxicology, and 8 Departments of Experimental and Evolutionary Biology, University of Bologna, Bologna, Italy; 9 Department of Life Science, National Chung Cheng University, Chia-Yi, Taiwan, Republic of China; and 10 Department of Blood and Bone Marrow Transplantation, University of Texas M. D. Anderson Cancer Center, Houston, Texas

Requests for reprints: Brett M. Hall, Center for Childhood Cancer, WA5015, Nationwide Children's Hospital, 700 Children's Drive, Columbus, OH 43205. Phone: 614-355-2650; Fax: 614-722-5895; E-mail: hall.125{at}osu.edu or Massimiliano Bonafé, Department of Experimental Pathology, University of Bologna, Via S. Giacomo 12, 40126 Bologna, Italy. Phone: 39-051-636-4009; Fax: 39-051-636-3902; E-mail: massimiliano.bonafe{at}unibo.it.

Key Words: fibroblast • tumor microenvironment • breast cancer • metastasis • interleukin-6 • seed and soil • three-dimensional

Common sites of breast cancer metastasis include the lung, liver, and bone, and of these secondary metastatic sites, estrogen receptor {alpha} (ER{alpha})–positive breast cancer often favors bone. Within secondary organs, cancer cells would predictably encounter tissue-specific fibroblasts or their soluble factors, yet our understanding of how tissue-specific fibroblasts directly affect cancer cell growth rates and survival remains largely unknown. Therefore, we tested the hypothesis that mesenchymal fibroblasts isolated from common sites of breast cancer metastasis provide a more favorable microenvironment with respect to tumor growth rates. We found a direct correlation between the ability of breast, lung, and bone fibroblasts to enhance ER{alpha}-positive breast cancer cell growth and the level of soluble interleukin-6 (IL-6) produced by each organ-specific fibroblast, and fibroblast-mediated growth enhancement was inhibited by the removal or inhibition of IL-6. Interestingly, mice coinjected with MCF-7 breast tumor cells and senescent skin fibroblasts, which secrete IL-6, developed tumors, whereas mice coinjected with presenescent skin fibroblasts that produce little to no IL-6 failed to form xenograft tumors. We subsequently determined that IL-6 promoted growth and invasion of breast cancer cells through signal transducer and activator of transcription 3–dependent up-regulation of Notch-3, Jagged-1, and carbonic anhydrase IX. These data suggest that tissue-specific fibroblasts and the factors they produce can promote breast cancer disease progression and may represent attractive targets for development of new therapeutics. [Cancer Res 2008;68(21):9087–95]




This article has been cited by other articles:


Home page
J. Immunol.Home page
Y. Lu, W. Yang, C. Qin, L. Zhang, J. Deng, S. Liu, and Z. Qin
Responsiveness of Stromal Fibroblasts to IFN-{gamma} Blocks Tumor Growth via Angiostasis
J. Immunol., November 15, 2009; 183(10): 6413 - 6421.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
H Chang, N Mohabir, S Done, and P A Hamel
Loss of ALX4 expression in epithelial cells and adjacent stromal cells in breast cancer
J. Clin. Pathol., October 1, 2009; 62(10): 908 - 914.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2008 by the American Association for Cancer Research.